Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy

British Medical Bulletin

Volumn 54, Issue 1, 1998, Pages 121-138

  McColl, K E L ^a   El Omar, E ^a   Gillen, D ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; PROTON PUMP INHIBITOR;

BACTERIAL COLONIZATION; DISEASE SEVERITY; DUODENUM ULCER; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; STOMACH ANTRUM; STOMACH CANCER;

EID: 0031905992     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011663     Document Type: Review

References (64)

1. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Kochs postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436-9
2. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192-9
3. Sobala GM, Crabtree JE, Dixon MF et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991; 32: 1415-8
4. Graham DY, Alpert LC, Smith JL, Yoshimura HH. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988; 83: 974-80
5. Morris A, Nicholson G. Experimental and accidental C. pylori infection of humans. In: Blaser MJ. (ed) Campylobacter pylori in Gastritis and Peptic Ulcer Disease. New York: Igaku-Shoin, 1989; 61-72
6. Dixon MF. IV Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol 1991; 6: 125-30
7. El-Omar E, Penman I, Dorrian CA, Ardill JES, McColl KEL. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34: 1060-5
8. El-Omar E, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-91
9. McColl KEL, Fullarton GM, Nujumi AM, Macdonald AM, Brown IL, Hilditch TE. Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet, 1989; ii: 499-500
10. McColl KEL, Fullarton GM, Chittajallu R et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 339-46
11. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; ii: 1167-8
12. Oderda G, Vaira D, Holton J, Ainley C, Altare F, Ansaldi N. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1989; ii: 690-2
13. Graham DY, Opekum A, Lew GM, Evans DJ, Klein PD, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter pylori (Campylobacter) pylori infection. Am J Gastroenterol 1990; 85: 394-8
14. Smith JTL, Pounder RE, Nwokolo CU et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990; 31: 522-5
15. Chittajallu RS, Dorrian CA, Neithercut WD, Dahill S, McColl KEL. Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? Gut 1991; 32: 1286-90
16. Graham DY, Go MF, Lew GM, Genta RM, Rehfeld JF. Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scand J Gastroenterol 1993; 28: 690-4
17. Mulholland G, Ardill JES, Fillmore D, Chittajallu RS, Fullarton GM, McColl KEL. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in Gastrin-17. Gut 1993; 34: 757-61
18. Kaneko H, Nakada K, Mitsuma T et al. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci 1992; 37: 409-16
19. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-2
20. Queiroz DMM, Mendes EN, Rocha GA et al. Effect of Helicobacter pylori eradication on antral gastrin-and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 1993; 28: 858-64
21. Sumii M, Summi K, Tari A et al. Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects. Am J Gastroenterol 1994; 89: 1515-9
22. Tarnasky PR, Kovacs TOG, Sytnik B, Walsh JH. Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Dig Dis Sci 1993; 38: 1681-7
23. Konturek JW, Konturek SJ, Domschke W. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. Scand J Gastroenterol 1995; 30: 738-44
24. Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of H. pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995; 37: 482-7
25. Chittajallu RS, Neithercut WD, Macdonald AMI, McColl KEL. Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. Gut 1991; 32: 21-4
26. El-Nujumi AM, Dorrian CA, Chittajallu RS, Neithercut WD, McColl KEL. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut 1991; 32: 866-70
27. Koop H, Willemer S, Steinbach F, Eissele R, Tuch K, Arnold R. Influence of chronic drug-induced achlorhydria by substituted benzimadazoles on the endocrine stomach in rats. Gastroenterology 1987; 92: 406-13
28. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-7
29. Crowe SE, Alvarez L, Dytoc M et al. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 1995; 108: 65-74
30. Beales ILP, Calam J. Helicobacter pylori infection and exogenous tumour necrosis factor alpha (TNFα) produce similar effects on gastrin release from human antral fragments. Gut 1996; 38 (Suppl.): A12
31. Courillon-Malet A, Launay J-M, Roucayrol A-M et al. Helicobacter pylori infection: physiopathologic implication of N-α-methyl histamine. Gastroenterology 1995; 108: 959-66
32. 3-receptors are coupled to inhibition of somatostatin secretion in the fundus and antrum of the stomach. Gastroenterology 1993; 104 Part 2: A854
33. 3-receptors on antral somatostatin cells are involved in the regulation of gastrin secretion from human and rat stomach. Gastroenterology 1994; 106: A207
34. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut, 1993; 34: 888-92
35. Harris AW, Gummett PA, Misiewicz JJ, Baron JH. Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid output to gastrin releasing peptide and pentagastrin. Gut 1996; 38: 663-7
36. Hamlet A, Olbe L. The influence of Helicobacter pylori on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology 1996; 111: 391-400
37. Hogan DL, Rapier RC, Dreilinger A et al. Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology 1996; 110: 705-16
38. Khulusi S, Badve S, Patel P et al. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology 1996; 110: 452-8
39. Banerjee S, El-Omar E, Mowat A et al. Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology 1996; 110: 717-24
40. Gillen DG, El-Omar E, Wirz A, Ardill JES, McColl KEL. The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori infected healthy volunteers. Gastroenterology 1998; 114: January
41. Yasunaga Y, Shinomura Y, Kanayama S et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35: 1571-4
42. El-Omar E, Oien K, El-Nujumi A et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24
43. Cave DR, King WW, Hoffman JS. Production of two chemically distinct acid-inhibitory factors by Helicobacter pylori. Eur J Gastroenterol Hepatol 1993; 5 (Suppl. 1): S23-7
44. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJH, Tytgate GNJ. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-9
45. Wallace JL, Cucala M, Mugridge K, Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991; 261: G559-64
46. Negrini R, Savio A, Poiesi C et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111: 655-65
47. Comfort MW. Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance. Ann Intern Med 1951; 34: 1331-47
48. Parsonnet J. Helicobacter pylori in the stomach - a paradox unmasked. N Engl J Med 1996; 335: 278-80
49. Hill MJ. Bacterial N-nitrosation and gastric carcinogenesis in humans. Ital J Gastroenterol 1991; 23: 17-23
50. Sobala GM, Pignatelli B, Schorah CJ et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 1991; 12: 193-8
51. Ruiz B, Rood JC, Fontham ETH et al. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994; 89: 533-9
52. Mackerness CW, Leach SA, Thompson MH, Hill MJ. The inhibition of bacterially mediated N-nitrosation by vitamin C: relevance to the inhibition of endogenous N-nitrosation in the achlorhydric stomach. Carcinogenesis 1989; 10: 397-9
53. El-Omar E, Oien K, Wirz A et al. H. pylori-induced hypochlorhydria is associated with increased risk of gastric cancer. Gut 1997; 40 (Suppl.): A83
54. Hansen S, Vollset SE, Ardill JES et al. Hypergastrinaemia is a strong predictor of distal adenocarcinoma among H. pylori infected subjects. Gut 1997; 40 (Suppl.): A46
55. Covacci A, Censini S, Bugnoli M et al. Molecular characterisation of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5
56. Blaser MJ, Perez Perez GI, Kleanthous H et al. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5
57. Joossens JV, Hill MJ, Elliott P et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. Int J Epidemiol 1996; 25: 494-504
58. Kuipers EJ, Uyterlinde AM, Pena AS et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995; 90: 1401-6
59. Hui WM, Lam SK, Ho J et al. Effect of omeprazole on duodenal ulcer associated antral gastritis and Helicobacter pylori. Dig Dis Sci 1991; 36: 577-82
60. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-6
61. Labenz J, Tillenburg B, Peitz U et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-32
62. Verdu EF, Armstrong D, Idstrom J-P et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37: 743-8
63. Gillen DG, Wirz A, McColl KEL. Degree of suppression of gastric acid secretion by omeprazole is related to H. pylori status. Gastroenterology 1997; 112: A126
64. Kuipers EJ, Lee A, Klinkenberg-Knol EC, Meuwissen SGM. Review article: the development of atrophic gastritis - Helicobacter pylori and the effects of acid suppressive therapy. Aliment Pharmacol Ther 1995; 9: 331-40